Molecular markers in the surgical margin of oral carcinomas

Journal of Oral Pathology and Medicine

Volumn 38, Issue 1, 2009, Pages 72-78

  Bilde, Anders ^a   Von Buchwald, Christian ^a   Dabelsteen, Erik ^b   Therkildsen, Marianne Hamilton ^a   Dabelsteen, Sally ^b  

^a Copenhagen University Hospital ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chk2; Glycosylated oncofetal fibronectin; Laminin 5; Oral cancer; Oral squamous cell carcinoma; P16; P53; Surgical margin

Indexed keywords

CHECKPOINT KINASE 2; FIBRONECTIN; KALININ; MOLECULAR MARKER; PROTEIN GLYCOSYLATED ONCOFETAL FIBRONECTIN; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING;

ADULT; AGED; BASEMENT MEMBRANE; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL AGING; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOPLASM; DNA REPLICATION; EPITHELIUM; FEMALE; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 58149153112     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00715.x     Document Type: Article

References (45)

1. Hansen HS, Overgaard J, Jorgensen KE. DAHANCA (Danish head and neck cancer) - 20 years of cooperation. Ugeskr Laeger 1998 160 : 821 6.
2. Looser KG, Shah JP, Strong EW. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978 1 : 107 11.
3. Byers RM, Bland KI, Borlase B, Luna M. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg 1978 136 : 525 8.
4. Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 1990 160 : 410 4.
5. Chen TY, Emrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys 1987 13 : 833 7.
6. Collado M, Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006 6 : 472 6.
7. Bartkova J, Rezaei N, Liontos M, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006 444 : 633 7.
8. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005 434 : 864 70.
9. Kato K, Hara A, Kuno T, et al. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol 2006 132 : 735 43.
10. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995 332 : 429 35.
11. Partridge M, Li SR, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000 6 : 2718 25.
12. van Houten VM, Leemans CR, Kummer JA, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res 2004 10 : 3614 20.
13. Fearon ER. Genetic alterations underlying colorectal tumorigenesis. Cancer Surv 1992 12 : 119 36.
14. Braakhuis BJ, Leemans CR, Brakenhoff RH. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 2004 33 : 317 22.
15. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953 6 : 963 8.
16. Chandar N, Billig B, McMaster J, Novak J. Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer 1992 65 : 208 14.
17. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994 54 : 1169 74.
18. Natarajan E, Saeb M, Crum CP, Woo SB, McKee PH, Rheinwald JG. Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol 2003 163 : 477 91.
19. Thorup AK, Dabelsteen E, Schou S, Gil SG, Carter WG, Reibel J. Differential expression of integrins and laminin-5 in normal oral epithelia. APMIS 1997 105 : 519 30.
20. Matsuura H, Takio K, Titani K, et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem 1988 263 : 3314 22.
21. Dabelsteen E. Quantitative determination of blood group substances A of oral epithelial cells by immunofluorescence and immunoperoxidase methods. Acta Pathol Microbiol Scand [A] 1972 80 : 847 53.
22. Wandall HH, Dabelsteen S, Sorensen JA, Krogdahl A, Mandel U, Dabelsteen E. Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: the production of glycosylated onco-foetal fibronectin by carcinoma cells. Oral Oncol 2007 43 : 301 9.
23. Batsakis JG. Surgical excision margins: a pathologist's perspective. Adv Anat Pathol 1999 6 : 140 8.
24. Califano J, van der RP, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996 56 : 2488 92.
25. Tabor MP, Brakenhoff RH, van Houten VM, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001 7 : 1523 32.
26. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000 6 : 324 9.
27. Natarajan E, Omobono JD, Jones JC, Rheinwald JG. Co-expression of p16INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression. J Investig Dermatol Symp Proc 2005 10 : 72 85.
28. Dabelsteen E, Gron B, Mandel U, Mackenzie I. Altered expression of epithelial cell surface glycoconjugates and intermediate filaments at the margins of mucosal wounds. J Invest Dermatol 1998 111 : 592 7.
29. Pyke C, Romer J, Kallunki P, et al. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 1994 145 : 782 91.
30. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001 264 : 42 55.
31. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996 56 : 3630 3.
32. Bradley KT, Budnick SD, Logani S. Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity. Mod Pathol 2006 19 : 1310 6.
33. Shintani S, Mihara M, Nakahara Y, et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002 38 : 235 43.
34. Pande P, Mathur M, Shukla NK, Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 1998 34 : 396 403.
35. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000 29 : 413 25.
36. van Oijen MG, van de Craats JG, Slootweg PJ. p53 overexpression in oral mucosa in relation to smoking. J Pathol 1999 187 : 469 74.
37. McCluggage WG, Connolly LE, McGregor G, Hyland PL, Hall PA. A strategy for defining biologically relevant levels of p53 protein expression in clinical samples with reference to endometrial neoplasia. Int J Gynecol Pathol 2005 24 : 307 12.
38. Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium. J Oral Pathol Med 2008 37 : 549 554.
39. Cruz IB, Meijer CJ, Snijders PJ, Snow GB, Walboomers JM, van Der Waal I. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management. J Pathol 2000 191 : 132 7.
40. Cruz IB, Snijders PJ, Meijer CJ, et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998 184 : 360 8.
41. Kushner J, Bradley G, Jordan RC. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J Pathol 1997 183 : 418 23.
42. Thurfjell N, Coates PJ, Uusitalo T, et al. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. Int J Oncol 2004 25 : 27 35.
43. Tudor D, Locke M, Owen-Jones E, Mackenzie IC. Intrinsic patterns of behavior of epithelial stem cells. J Investig Dermatol Symp Proc 2004 9 : 208 14.
44. Costea DE, Tsinkalovsky O, Vintermyr OK, Johannessen AC, Mackenzie IC. Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis 2006 12 : 443 54.
45. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000 408 : 307 10.